Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 53651-53660 Newer>

The Motley Fool November 23, 2011 Chuck Saletta	How I Earned 20% More Than Last Year If you're investing for your retirement, there's one very important performance metric that you're not likely already tracking. That metric is your year-over-year change in dividend income.
The Motley Fool November 23, 2011 Sean Williams	Brocade Tells Fat Lady to Hold Her Tongue Brocade's not ready to go quietly into the night just yet.
The Motley Fool November 23, 2011 Alex Planes	Give Thanks for These 7 Stocks These companies have given us a lot to be thankful for.
The Motley Fool November 23, 2011 Alex Dumortier	My Surreal Life: Jon Corzine Fact is sometimes stranger than fiction.
The Motley Fool November 23, 2011 Anders Bylund	FCC and DOJ Double-Team to Take Down AT&T-Mobile The feds are killing this blockbuster merger. Good move too, unless you're an AT&T shareholder.
The Motley Fool November 23, 2011 Rick Aristotle Munarriz	Pandora's All Ears The music streaming site has another strong quarter. Pandora's growth party is just getting started.
The Motley Fool November 22, 2011 Dan Radovsky	S&P Drops the Hammer on Clearwire Clearwire joins its frenemy Sprint with a credit-rating downgrade.
The Motley Fool November 22, 2011 Jordan DiPietro	Now Could Be the Best Time to Buy This Stock After a significant drop in share price, this might be the time to buy Activision.
The Motley Fool November 22, 2011 Tamara Rutter	Profits You Can Touch A rise in smartphone sales is cash in the pockets of these companies.
The Motley Fool November 22, 2011 Brian Orelli	This Spec Pharma Hopes Convenience Trumps All Spectrum Pharmaceuticals' Zevalin no longer requires a bioscan.
<Older 53651-53660 Newer> Return to current articles.